The 10th Nanjing International Conference will be held on December 11-13, 2020 at Nanjing Shuguang International Hotel. At that time, Yidu Zhengkang will wait for your arrival at Booth No. 11. On the morning of December 11, there will be a pre-meeting training course, including offline affection speeches by excellent domestic DMPK experts and speeches by 8 senior foreign DMPK researchers. This conference will bring you the sharing of valuable experience in DMPK research of innovative drugs at home and abroad and the presentation of the latest research progress.

Since 2002, the third Wednesday of November of each year has been established as World Chronic Obstructive Pulmonary Disease Day, through the active initiative of multinational respiratory disease experts. Each year, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) selects a theme to coordinate global resources to prepare for various activities in order to improve the understanding of chronic obstructive pulmonary disease (COPD).

Today is United Nations Diabetes Day, formerly World Diabetes Day (WDD). At the end of 2006, the United Nations adopted a resolution to officially rename "World Diabetes Day" as "United Nations Diabetes Day" from 2007, raise experts and academic behaviors to government behaviors of various countries, promote governments and all sectors of society to strengthen the control of diabetes and reduce the harm of diabetes.
According to the World Health Organization, one person dies of diabetes every 10 seconds and one person is amputated due to diabetes every 30 seconds worldwide, and China has 130 million diabetic patients today, ranking first in the world. Diabetes drugs are already the second most common drug after oncology drugs, so let's understand the classification of diabetes drugs before.

In the golden autumn of October, also a harvest season, the 4th China Innovative Drug Forum, sponsored by Chinese Journal of New Drugs, was successfully held on October 17-18, 2020.

The second day meeting of the Fourth China Forum on Innovative Drugs is still brilliant and full of seats. Today's forum is divided into four parts, namely, R & D and clinical study of new drugs of traditional Chinese medicine (sub-forum 1), risk and quality management of clinical trials (sub-forum 2), pharmacoeconomics and medical insurance forum (sub-forum 3) and biomedical frontier forum (sub-forum 4). We also bring you live broadcast reports on the speech content of speakers in part 2 of the sub-forum: